Literature DB >> 10773127

Limits of infrapopliteal bypass surgery for critical leg ischemia: when not to reconstruct.

F Biancari1, I Kantonen, A Albäck, S Mätzke, M Luther, M Lepäntalo.   

Abstract

The aim of this study was to identify the risk factors affecting the immediate 30-day postoperative outcome of infrapopliteal bypass grafts. A series of 511 revascularization procedures to the infrapopliteal arteries have been performed in 439 patients with critical leg ischemia. There were 306 crural bypasses and 205 pedal bypasses. The 30-day postoperative primary and secondary patency rates were 77.5% and 83.4%, respectively; the leg salvage rate was 89.8%; the survival rate was 94.7%; and 85.1% of patients were alive with a salvaged leg. A history of myocardial infarction, angina pectoris, or stroke had a great impact on the postoperative cardiac and cerebrovascular fatal and nonfatal complications. C-reactive protein arose as an important predictor of the length of hospital stay (p = 0.03), postoperative cardiac complications (p = 0.02), leg salvage (p = 0.009), amputation with patent graft (p = 0.009), and patients who survived with a salvaged leg (p = 0.006). Poor results were achieved in patients on long-term dialysis. Surgical experience had an influence on leg salvage (p = 0.02) and on patients alive with salvaged leg rates (p = 0.009). Infrapopliteal bypass surgery is a demanding procedure requiring high surgical skill and experience. Revascularization may be contraindicated when severe coronary disease, previous stroke, renal failure requiring long-term dialysis, diabetes, or high serum concentration of C-reactive protein coexist with critical leg ischemia, as these patients are at high risk for early postoperative leg or life loss.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10773127     DOI: 10.1007/s002689910117

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  3 in total

1.  Risk-scoring method for prediction of 30-day postoperative outcome after infrainguinal surgical revascularization for critical lower-limb ischemia: a Finnvasc registry study.

Authors:  Fausto Biancari; Juha-Pekka Salenius; Maarit Heikkinen; Michael Luther; Kari Ylönen; Mauri Lepäntalo
Journal:  World J Surg       Date:  2007-01       Impact factor: 3.352

2.  The role of chronic kidney disease as a predictor of outcome after revascularisation of the ulcerated diabetic foot.

Authors:  M Venermo; F Biancari; E Arvela; M Korhonen; M Söderström; K Halmesmäki; A Albäck; M Lepäntalo
Journal:  Diabetologia       Date:  2011-08-16       Impact factor: 10.122

3.  Clinical features and patency rates of Remedy® biodegradable peripheral stents.

Authors:  Selma Kenar Tiryakioglu; Osman Tiryakioglu; Oguz Karahan; Sinan Demirtas; Fatih Gokalp; Kamuran Erkoc; Hakan Özkan; Ahmet Ozyazicioglu
Journal:  Cardiovasc J Afr       Date:  2016-01-26       Impact factor: 1.167

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.